AstraZeneca’s Fasenra Wins FDA Approval for Rare Vasculitis
PremiumCompany AnnouncementsAstraZeneca’s Fasenra Wins FDA Approval for Rare Vasculitis
3d ago
AstraZeneca announces HIMALAYA trial demonstrated overall survival benefit
Premium
The Fly
AstraZeneca announces HIMALAYA trial demonstrated overall survival benefit
4d ago
AstraZeneca announces updated results from HIMALAYA Phase III trial of Imjudo
Premium
The Fly
AstraZeneca announces updated results from HIMALAYA Phase III trial of Imjudo
4d ago
Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
PremiumThe FlySalesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
9d ago
Erste upgrades AstraZeneca to Buy on strong oncology sales growth
Premium
The Fly
Erste upgrades AstraZeneca to Buy on strong oncology sales growth
9d ago
AstraZeneca upgraded to Buy from Hold at Erste Group
Premium
The Fly
AstraZeneca upgraded to Buy from Hold at Erste Group
9d ago
AstraZeneca says Dato-DXd showed clinically meaningful trend toward improving OS
PremiumThe FlyAstraZeneca says Dato-DXd showed clinically meaningful trend toward improving OS
11d ago
AstraZeneca put volume heavy and directionally bearish
Premium
The Fly
AstraZeneca put volume heavy and directionally bearish
11d ago
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
Premium
The Fly
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
11d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100